Oncology Institute (DFPH) Long-Term Deferred Tax (2019 - 2020)

Oncology Institute (DFPH) reported Long-Term Deferred Tax of $70000.0 for Q3 2020, up 79.49% quarter-over-quarter from $39000.0 in Q2 2020.

Oncology Institute (DFPH) Long-Term Deferred Tax (2019 - 2020) Analysis & Trends

Oncology Institute has reported Long-Term Deferred Tax for 2 years, with the latest figure at $70000.0 in Q3 2020.

For the quarter ending Q3 2020, Long-Term Deferred Tax changed N/A year-over-year to $70000.0; the trailing twelve-month figure through Sep 2020 stood at $70000.0 (changed N/A YoY), and the FY2019 full-year result was $300.0, changed N/A from the prior year.
Long-Term Deferred Tax for Q3 2020 stood at $70000.0, up from $39000.0 in the prior quarter.
The five-year high for Long-Term Deferred Tax was $70000.0 in Q3 2020, with the low at $300.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	83.85 Bn	86.23 Bn	16.26 Bn
2	Tenet Healthcare	14.98 Bn	14.15 Bn	4.41 Bn
3	Davita	13.99 Bn	14.84 Bn	1.07 Bn
4	Encompass Health	9.72 Bn	10.34 Bn	1.34 Bn
5	Ensign	8.90 Bn	8.31 Bn	293.37 Mn
6	Universal Health Services	8.59 Bn	8.55 Bn	3.21 Bn
7	Fresenius Medical Care AG	7.67 Bn	5.29 Bn	-4.26 Bn
8	Chemed	5.97 Bn	5.96 Bn	215.76 Mn
9	Pacs	5.74 Bn	5.50 Bn	345.96 Mn
10	Oncology Institute	-	-	139.16 Mn

Download Data